Evidence map›Paper›PMID 33407248›Full record

ArticleBMC pediatrics2021

The MEDEA childhood asthma study design for mitigation of desert dust health effects: implementation of novel methods for assessment of air pollution exposure and lessons learned.

Panayiotis Kouis, Stefania I Papatheodorou, Maria G Kakkoura, Nicos Middleton, Emmanuel Galanakis, Eleni Michaelidi, Souzana Achilleos, Nikolaos Mihalopoulos, Marina Neophytou, Gerasimos Stamatelatos and 6 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03503812 (Mitigating the Health Effects of Desert Dust Storms Using Exposure-Reduction Approaches), which is not on this map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03503812 nacompletednot on this map

Mitigating the Health Effects of Desert Dust Storms Using Exposure-Reduction Approaches: Assessment of Health Outcomes in Children With Asthma and in Adults With Atrial Fibrillation During Desert Dust Storms (With vs Without Interventions)

TypeinterventionalSponsorUniversity of CyprusRan2018 to 2022Enrolled310ConditionsAsthma in Children, Atrial FibrillationArmsIntervention (1) for outdoor exposure reduction - Asthma in Children, Intervention (2) for outdoor and indoor exposure reduction - Asthma in Children, Intervention (1) for outdoor exposure reduction - Atrial Fibrillation, Intervention (2) for outdoor and indoor exposure reduction - Atrial Fibrillation
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Digital health for climate change mitigation and response: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2022
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 5 countries.

Panayiotis KouisRespiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus. kouis.panayiotis@ucy.ac.cy.ORCID 0000-0003-0511-5352
Stefania I PapatheodorouCyprus International Institute for Environmental & Public Health, Cyprus University of Technology, Limassol, Cyprus.
Maria G KakkouraRespiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.
Nicos MiddletonDepartment of Nursing, Cyprus University of Technology, Limassol, Cyprus.
Emmanuel GalanakisMedical School, University of Crete, Heraklion, Crete, Greece.
Eleni MichaelidiMedical School, University of Crete, Heraklion, Crete, Greece.
Souzana AchilleosCyprus International Institute for Environmental & Public Health, Cyprus University of Technology, Limassol, Cyprus.
Nikolaos MihalopoulosDepartment of Chemistry, University of Crete, Heraklion, Greece.
Marina NeophytouDepartment of Civil & Environmental Engineering, University of Cyprus, Nicosia, Cyprus.
Gerasimos StamatelatosE.n.A Consulting LP, Arachova Boeotia, Greece.
Christos KaniklidesCyprus Broadcasting Corporation, Nicosia, Cyprus.
Efstathios RevvasDepartment of Meteorology, Ministry of Agriculture, Rural Development and Environment, Nicosia, Cyprus.
Filippos TymviosDepartment of Meteorology, Ministry of Agriculture, Rural Development and Environment, Nicosia, Cyprus.
Chrysanthos SavvidesDepartment of Labor Inspection, Ministry of Labor, Welfare and Social Insurance, Nicosia, Cyprus.
Petros KoutrakisDepartment of Environmental Health, Harvard TH Chan School of Public Health, Boston, USA.
Panayiotis K YiallourosRespiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.
University of Cyprus · CYUniversity of Crete · GRCyprus University of Technology · CYHarvard University · USMinistry of Agriculture, Natural Resources and Environment · CYCentral Bank of Cyprus · CYMinistry of Health Labour and Welfare · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDesert dust events in Mediterranean countries, originating mostly from the Sahara and Arabian deserts, have been linked to climate change and are associated with significant increase in mortality and hospital admissions from respiratory causes. The MEDEA clinical intervention study in children with asthma is funded by EU LIFE+ program to evaluate the efficacy of recommendations aiming to reduce exposure to desert dust and related health effects.

methodsThis paper describes the design, methods, and challenges of the MEDEA childhood asthma study, which is performed in two highly exposed regions of the Eastern Mediterranean: Cyprus and Greece-Crete. Eligible children are recruited using screening surveys performed at primary schools and are randomized to three parallel intervention groups: a) no intervention for desert dust events, b) interventions for outdoor exposure reduction, and c) interventions for both outdoor and indoor exposure reduction. At baseline visits, participants are enrolled on MEDena® Health-Hub, which communicates, alerts and provides exposure reduction recommendations in anticipation of desert dust events. MEDEA employs novel environmental epidemiology and telemedicine methods including wearable GPS, actigraphy, health parameters sensors as well as indoor and outdoor air pollution samplers to assess study participants' compliance to recommendations, air pollutant exposures in homes and schools, and disease related clinical outcomes. DISCUSSION: The MEDEA study evaluates, for the first time, interventions aiming to reduce desert dust exposure and implement novel telemedicine methods in assessing clinical outcomes and personal compliance to recommendations. In Cyprus and Crete, during the first study period (February-May 2019), a total of 91 children participated in the trial while for the second study period (February-May 2020), another 120 children completed data collection. Recruitment for the third study period (February-May 2021) is underway. In this paper, we also present the unique challenges faced during the implementation of novel methodologies to reduce air pollution exposure in children. Engagement of families of asthmatic children, schools and local communities, is critical. Successful study completion will provide the knowledge for informed decision-making both at national and international level for mitigating the health effects of desert dust events in South-Eastern Europe.

trial registrationClinicalTrials.gov: NCT03503812 , April 20, 2018.

Indexed as

Air PollutionAir Pollution, IndoorAsthmaAfrica, NorthernChildDustEnvironmental ExposureEurope, EasternGreeceHumansRandomized Controlled Trials as TopicDustAsian dustAsthmaChildrenDesert dustPublic health intervention

Identifiers

PMID33407248
PMCPMC7786906
OpenAlexW3119707149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.